Novo Nordisk

Sanofi’s diabetes combo on target for showdown with Novo

https://pharmaphorum.com/news/sanofis-insulin-glp-1-diabetes-combo-target/

Pharma looking to dual-action diabetes drugs to boost sales

https://pharmaphorum.com/news/pharma-looking-dual-action-diabetes-drugs-boost-sales/

Novo Nordisk buoyed by Victoza cardiovascular results

https://pharmaphorum.com/news/novo-nordisk-buoyed-by-victoza-cardiovascular-results/

Delivering pharma innovation: Takeda and Novo Nordisk on the rise

https://pharmaphorum.com/articles/delivering-pharma-innovation-takeda-and-novo-nordisk-on-the-rise/

Can Novo Nordisk’s pipeline transform obesity treatment?

https://pharmaphorum.com/articles/can-novo-nordisk-s-pipeline-transform-obesity-treatment/

«< 8 9 10 11 12

Close in 10 seconds

Pharmaphorum.com

Search